Dr. Weisskoff has worked extensively in both academia and the bioscience industry for the past twenty years. Prior to joining Fidelity in 2004, he held various senior roles in R&D and Business Development at both pharmaceutical and medical device companies. In his academic career, Dr. Weisskoff was Associate Professor of Radiology at Harvard Medical School, and on the faculty of the Harvard-MIT Health Sciences Technology (HST) Program, and performed research at Massachusetts General Hospital, where he was Associate Director of the MGH-NMR Center. There he worked at the intersection of basic research, medical technology development, and clinical research in a variety of areas. Robert is the author of over 100 peer-reviewed scientific papers, and an inventor on 5 US patents.

Dr. Weisskoff holds a Ph.D. in Physics from the Massachusetts Institute of Technology and an M.B.A. from Columbia University. He received his A.B. degree in Physics from Harvard University, graduating magna cum laude and Phi Beta Kappa.

Dr. Weisskoff currently serves on the Board of Directors for Acorn, Accuri Cytometers, Bioconnect, EnVivo Pharmaceuticals, Ikano Therapeutics, Inc., Tetraphase, Topaz, Transave and ViewRay.